摘要
阿尔茨海默病是一种严重的退行性疾病,主要发生在典型的发达国家。在非洲发病率比例只有2.6%,而在美国是6.5%,在西欧7.2%。总的来说,这种疾病在全世界影响4400万人。观察人口的发展, 预计在未来会有更多人患有阿尔茨海默病。关键问题不仅是一个有效的药物的发现,早期诊断,预防和对患有阿尔茨海默病的人的关心,而且在于提供一个等价的崛起的社会健康机构。 因为治疗阿尔茨海默病(AD)将会带来严重的经济和社会负担,本研究的主要目的是分析和比较可用的后备手段来预防和治疗阿尔茨海默病的患者并特别关注他们的认知能力。此外,分析还集中在世界各个国家药理保健的成本。这是通过使用德拉蒙德的方法论的直接和间接成本的方法。在后备手段分析的基础上进行临床和审查研究,比较和评估他们的发现的相关文献综述与研究问题的数据库是被承认的。
关键词: 阿尔茨海默病、比较成本、后备手段。
Current Alzheimer Research
Title:Non-Pharmacological Approaches to the Prevention and Treatment of Alzheimer’s Disease with Respect to the Rising Treatment Costs
Volume: 13 Issue: 11
Author(s): Blanka Klimova, Petra Maresova, Kamil Kuca
Affiliation:
关键词: 阿尔茨海默病、比较成本、后备手段。
摘要: Alzheimer’s disease is a serious degenerative disease which is mainly typical of the developed countries. The prevalence percentage in Africa is only 2.6 %, whereas in America it is 6.5 % and in Western Europe 7.2 %. Overall, this disease affects 44 million people worldwide. With respect to the demographic development, a number of people suffering from Alzheimer’s disease is expected in future. The key issue is not only the discovery of an effective medication, but also the early diagnosis, prevention and care about people with AD, as well as the provision of an equivalent rise of places in health and social institutions.
Since the treatment of Alzheimer’s disease (AD) imposes a severe economic and social burden, the main purpose of this study is to analyze and compare available non-pharmacological approaches to the prevention and treatment of patients with AD with special focus on their cognitive competences. In addition, the analysis also concentrates on the costs of pharmacological care in individual countries all over world. This is done by using Drummond’s methodological approaches to direct and indirect costs. The analysis of non-pharmacological approaches is conducted on the basis of literature review of both clinical and review studies relevant for the research issue in the acknowledged databases and a comparison and evaluation of their findings.
Export Options
About this article
Cite this article as:
Blanka Klimova, Petra Maresova, Kamil Kuca , Non-Pharmacological Approaches to the Prevention and Treatment of Alzheimer’s Disease with Respect to the Rising Treatment Costs, Current Alzheimer Research 2016; 13 (11) . https://dx.doi.org/10.2174/1567205013666151116142302
DOI https://dx.doi.org/10.2174/1567205013666151116142302 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Current Pharmaceutical Design Cellular Mechanisms of Brain Injury and Cell Death
Current Pharmaceutical Design Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design Extracellular Superoxide Dismutase (EC-SOD) Quenches Free Radicals and Attenuates Age-Related Cognitive Decline: Opportunities for Novel Drug Development in Aging
Current Alzheimer Research Uncoupling Protein-2 and the Potential Link Between Metabolism and Longevity
Current Aging Science Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)
Current Pharmacogenomics and Personalized Medicine Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology Expanded Temporal Binding Windows in People with Mild Cognitive Impairment
Current Alzheimer Research Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma
Current Pharmaceutical Design The Progress of Epilepsy after Stroke
Current Neuropharmacology Optimizing ADAS-Cog Worksheets: A Survey of Clinical Trial Rater s’ Perceptions
Current Alzheimer Research Treatment of Anderson-Fabry Disease
Current Pharmaceutical Design Possible Usefulness of Growth Hormone/Insulin-like Growth Factor-I Axis in Alzheimer’s Disease Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis
Current Alzheimer Research Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis
Current Medicinal Chemistry Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design Strategies for the Recruitment and Retention of Racial/Ethnic Minorities in Alzheimer Disease and Dementia Clinical Research
Current Alzheimer Research Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer’s Disease Model Rats by Maintaining Synaptic Plasticity
CNS & Neurological Disorders - Drug Targets